RNR
Renaissancere Holdings Ltd
Renaissancere Holdings Ltd historical holders
total: 7
Egerton Capital Renaissancere Holdings Ltd transactions over time
- Total transactions:
- 12
- New positions:
- 2
- Sold out:
- 2
- Added:
- 6
- Reduced:
- 2
- Held since:
- 2025 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
John Armitage has been an institutional investor in Renaissancere Holdings Ltd (RNR) since 2023 Q1. According to 2026 Q2 report, John Armitage doesn't hold any shares. The fund/company first acquired RNR in 2023 Q1, initially purchasing 623,152 shares. John Armitage later completely sold out the position and reinvested in RNR again in 2025 Q4. Since the initial investment, Egerton Capital has made 11 more transactions in this position.
When did John Armitage exit their RNR position?
John Armitage no longer holds Renaissancere Holdings Ltd (RNR). They sold off their entire position in 2026 Q2, closing out an investment that began in 2023 Q1.
When did John Armitage first invest in RNR?
John Armitage first invested in Renaissancere Holdings Ltd (RNR) in 2023 Q1 at the reported quarter-end price of $200.34 per share, acquiring 623,152 shares in their initial purchase.
What is John Armitage's average cost basis for RNR?
Based on historical transaction data, John Armitage's estimated cost basis for Renaissancere Holdings Ltd (RNR) is approximately $281.16 per share. This represents their average reported price* across all buy transactions.
Has John Armitage reinvested in RNR after selling?
Yes, John Armitage has shown renewed interest in Renaissancere Holdings Ltd (RNR). After completely selling their position, they reinitiated an investment in 2025 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $281.16
- Weighted AVG sell price:
- $297.23
RNR transactions history by Egerton Capital
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$297.23
|
|
-100% (-317,308)
|
-1.05%
|
|
2026 Q1
|
1.05%
|
317,308
|
$297.23
|
$94,313,457
|
-35.33% (-173,318)
|
-0.56%
|
|
2025 Q4
|
1.50%
|
490,626
|
$281.16
|
$137,944,406
|
new
|
+1.5%
|
|
2025 Q1
|
0.00%
|
0
|
$248.81
|
|
-100% (-1,294,662)
|
-3.73%
|
|
2024 Q4
|
3.73%
|
1,294,662
|
$248.81
|
$322,124,852
|
-31.66% (-599,750)
|
-1.51%
|
|
2024 Q3
|
5.21%
|
1,894,412
|
$272.40
|
$516,037,829
|
+1.85% (+34,486)
|
+0.09%
|
|
2024 Q2
|
4.20%
|
1,859,926
|
$223.51
|
$415,712,060
|
+0.06% (+1,102)
|
+0%
|
|
2024 Q1
|
4.22%
|
1,858,824
|
$235.03
|
$436,879,405
|
+13.24% (+217,284)
|
+0.49%
|
|
2023 Q4
|
3.49%
|
1,641,540
|
$196.00
|
$321,741,840
|
+16.74% (+235,337)
|
+0.5%
|
|
2023 Q3
|
3.23%
|
1,406,203
|
$197.92
|
$278,315,698
|
+5.92% (+78,606)
|
+0.18%
|
|
2023 Q2
|
2.55%
|
$186.52
|
+113.05% (+704,445)
|
|||
|
2023 Q1
|
1.35%
|
$200.34
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.